Medicine and Dentistry
Breast Cancer
50%
Lung Cancer
50%
Decision Making
50%
Geographic Mapping
50%
American Indian
50%
COVID-19
50%
COVID-19 Diagnostics
50%
Trastuzumab
50%
Hypertension
45%
Chemotherapeutic Agent
25%
Drug
25%
Heart Tumor
25%
Atrial Myxoma
25%
Frailty
25%
Cancer Growth
25%
Lung Adenocarcinoma
25%
Cancer
25%
Disease Course
25%
Left Atrium
25%
Patient
20%
Odds Ratio
20%
Linear Regression Analysis
16%
Ecological Study
16%
Cancer Therapy
15%
Incidence
15%
Adverse Event
10%
Association
10%
Predictor
10%
Combination Therapy
10%
Discharge
10%
Inpatient
5%
Cancer Control
5%
Cardiotoxicity
5%
Complication
5%
Analysis
5%
Malignant Neoplasm
5%
Eribulin
5%
Side Effect
5%
Hospital Mortality
5%
Nursing and Health Professions
Patient
51%
Combination Therapy
50%
Trastuzumab
50%
Inpatient
50%
Breast Cancer
50%
Prediction
50%
Carcinoid Syndrome
50%
Diagnosis
50%
Health Service
50%
Heart Tumor
25%
Lung Adenocarcinoma
25%
Cancer Growth
25%
Cardiotoxicity
21%
Woman
18%
Incidence
18%
Low Risk Population
14%
Time
11%
Serotonin
9%
Complication
9%
Vasoactive Agent
9%
Symptom
9%
Neuroendocrine Tumor
9%
Carcinoid
9%
Predictive Value
7%
Procedures
7%
Heart Left Ventricle Ejection Fraction
7%
Screening
7%
Prevalence
7%
Sample
7%
Patient with Cancer
7%
Electronic Medical Record
7%
Sensitivity and Specificity
7%
Logistic Regression Analysis
7%
Cost Effectiveness Analysis
7%
Diseases
7%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Trastuzumab
50%
Anthracycline
50%
Trastuzumab
50%
Hypertension
45%
Incidence
29%
Cardiotoxicity
26%
Drug
25%
Lung Adenocarcinoma
25%
Heart Atrium Myxoma
25%
Heart Tumor
25%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
14%
Chemotherapy
10%
Adverse Event
10%
Prevalence
7%
Diseases
7%
Patient History of Coronary Artery Bypass Graft
7%
Eribulin
5%
Hospital Mortality
5%
Complication
5%
Side Effect
5%
Malignant Neoplasm
5%
